First Page | Document Content | |
---|---|---|
Date: 2016-03-09 17:09:48HealthCap Versant Chemotherapy | VERSANT VENTURES BACKS APREA AB CONTINUING GLOBAL INVESTMENT STRATEGY -- Tenth company sourced by firm’s European team in the past five years -- -- Developing first ever therapy targeting the tumor suppressing proteinAdd to Reading ListSource URL: www.versantventures.comDownload Document from Source WebsiteFile Size: 46,51 KBShare Document on Facebook |